The increased levels of pERK and pAKT in the bone cancer model evaluated in this study are in agreement with results from previous studies53, 54 demonstrating that pERK and pAKT levels in the spinal cord increase under conditions of inflammation and neuropathic pain55, 56. This evidence concerns the gene EIF2AK3 and bone neoplasm.